Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.

Item

http://www.wikidata.org/entity/Q35917852

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@ast

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en-gb

type

Item

label

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@ast

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en-gb

prefLabel

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@ast

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en-gb

P1476

Determinants of Early Mortalit ...... lon Cancer Endpoints Database.

@en

P2093

Aimery de Gramont

http://www.w3.org/2001/XMLSchema#string

Axel Grothey

http://www.w3.org/2001/XMLSchema#string

Chris O'Callaghan

http://www.w3.org/2001/XMLSchema#string

Chris Twelves

http://www.w3.org/2001/XMLSchema#string

Daniel G Haller

http://www.w3.org/2001/XMLSchema#string

Daniel J Sargent

http://www.w3.org/2001/XMLSchema#string

Eric Van Cutsem

http://www.w3.org/2001/XMLSchema#string

Guido Francini

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Seitz

http://www.w3.org/2001/XMLSchema#string

Katherine A Guthrie

http://www.w3.org/2001/XMLSchema#string

P2860

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.

P304

1182-1189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1200/JCO.2015.65.1158

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26858337

http://www.w3.org/2001/XMLSchema#string

P932

4933130

http://www.w3.org/2001/XMLSchema#string